Séverine Vermeire | Charles Explorer

A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn's Disease

2013 | Publikace bez příslušnosti k fakultě